TC BioPharm (Holdings) PLC (TCBP)
1.48
+0.05
(+3.50%)
USD |
NASDAQ |
May 01, 16:00
1.50
+0.02
(+1.35%)
After-Hours: 20:00
TC BioPharm Total Liabilities (Quarterly): 7.957M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.957M |
| June 30, 2023 | 7.848M |
| December 31, 2022 | 13.26M |
| June 30, 2022 | 15.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 33.18M |
| September 30, 2021 | 26.58M |
| December 31, 2020 | 14.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.848M
Minimum
Jun 2023
33.18M
Maximum
Dec 2021
16.93M
Average
14.46M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 243.10M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
| Mereo BioPharma Group PLC | 15.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.38M |
| Shareholders Equity (Quarterly) | 3.421M |